These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7800900)

  • 1. [The use of angiotensin-converting enzyme inhibitors in anterior infarct without congestive symptoms. The arguments contra].
    Rodríguez Lambert JL; Moris C
    Rev Esp Cardiol; 1994 Nov; 47(11):719-22. PubMed ID: 7800900
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of angiotensin-converting enzyme inhibitors in anterior infarct without congestive symptoms. The arguments pro].
    de Teresa E
    Rev Esp Cardiol; 1994 Nov; 47(11):723-8. PubMed ID: 7800901
    [No Abstract]   [Full Text] [Related]  

  • 3. [ACE inhibitors early after myocardial infarct].
    Heinzl S
    Med Monatsschr Pharm; 1994 Jul; 17(7):197. PubMed ID: 8090131
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value in heart failure proven again. AT II blocker soon also for post-infarct patients?].
    MMW Fortschr Med; 2003 Oct; 145(43):51. PubMed ID: 14664222
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress in angiotensin-converting enzyme inhibition in heart failure: rationale, mechanisms, and clinical responses.
    Dzau VJ; Creager MA
    Cardiol Clin; 1989 Feb; 7(1):119-30. PubMed ID: 2650868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?
    Dickstein K
    Am Heart J; 2003 May; 145(5):754-7. PubMed ID: 12766730
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of remodeling of the heart after myocardial infarction.
    Gorlin R
    Mt Sinai J Med; 1995 Sep; 62(4):287-92. PubMed ID: 7565851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
    Modesti PA; Vanni S; Gensini GF
    Ital Heart J Suppl; 2003 Aug; 4(8):623-34. PubMed ID: 14655458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease].
    Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A
    Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
    Tokmakova M; Solomon SD
    Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues concerning the use of angiotensin-converting enzyme inhibitors in the treatment of heart failure and myocardial infarction.
    Poole-Wilson PA
    Arch Mal Coeur Vaiss; 1994 Jun; 87 Spec No 2():35-8. PubMed ID: 7864720
    [No Abstract]   [Full Text] [Related]  

  • 13. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA; Movahed A
    Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing angiotensin-converting enzyme inhibitor trial results in patients with acute myocardial infarction.
    Cody RJ
    Arch Intern Med; 1994 Sep; 154(18):2029-36. PubMed ID: 8092908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of angiotensin-converting enzyme inhibitors in the treatment and prevention of congestive heart failure.
    Toher CA; Francis GS
    Coron Artery Dis; 1993 Jan; 4(1):37-43. PubMed ID: 8269182
    [No Abstract]   [Full Text] [Related]  

  • 16. ACE inhibitors for congestive heart failure.
    Med Lett Drugs Ther; 1988 Oct; 30(777):97-8. PubMed ID: 3173235
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of treatment of early forms and prevention of heart failure. Value of ACE inhibitors in therapy after myocardial infarct].
    Kleber FX; Baumann G
    Acta Med Austriaca; 1993; 20(4):95-9. PubMed ID: 8237284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors in hypertension and congestive heart failure.
    Gavras I; Gavras H
    Adv Intern Med; 1990; 35():249-67. PubMed ID: 2405595
    [No Abstract]   [Full Text] [Related]  

  • 20. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].
    Ferrari R; Ambrosio G; Chiariello M
    Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.